IFP Advisors’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
IFP Advisors's SLRN Position: Q3 2025 in Review
IFP Advisors sold out of ACELYRIN (SLRN) in Q3 2025, closing a stake of 3 shares — an estimated $7 sold.
IFP Advisors first reported a position in SLRN in Q2 2025 and held it in 1 quarter. The position peaked at $7 in Q2 2025. 0 funds tracked by Wall St. Rank hold SLRN as of Q3 2025.
- IFP Advisors reported no remaining ACELYRIN position as of Q3 2025 after selling out during the quarter.
- IFP Advisors sold 3 ACELYRIN shares in Q3 2025, an estimated $7.
- IFP Advisors first reported a position in ACELYRIN in Q2 2025 and held it in 1 quarter.
- IFP Advisors's ACELYRIN position peaked at $7 in Q2 2025.
- 0 funds tracked by Wall St. Rank held ACELYRIN as of Q3 2025.
Based on IFP Advisors's 13F filing for Q3 2025, filed 2 Dec 2025.